BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33557409)

  • 1. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
    Mathkar PP; Chen X; Sulovari A; Li D
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
    Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
    Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H; Gao HF; Ma GH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.
    Lee WY; Bachtiar M; Choo CCS; Lee CG
    Biol Rev Camb Philos Soc; 2019 Apr; 94(2):353-367. PubMed ID: 30105774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Patterns of HBV Integration and
    Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral integration drives multifocal HCC during the occult HBV infection.
    Chen XP; Long X; Jia WL; Wu HJ; Zhao J; Liang HF; Laurence A; Zhu J; Dong D; Chen Y; Lin L; Xia YD; Li WY; Li GB; Zhao ZK; Wu K; Hou Y; Yu JJ; Xiao W; Wang GP; Zhu PC; Chen W; Bai MZ; Jian YX; Kristiansen K; Chen Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):261. PubMed ID: 31200735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma.
    Péneau C; Imbeaud S; La Bella T; Hirsch TZ; Caruso S; Calderaro J; Paradis V; Blanc JF; Letouzé E; Nault JC; Amaddeo G; Zucman-Rossi J
    Gut; 2022 Mar; 71(3):616-626. PubMed ID: 33563643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A virome-wide clonal integration analysis platform for discovering cancer viral etiology.
    Chen X; Kost J; Sulovari A; Wong N; Liang WS; Cao J; Li D
    Genome Res; 2019 May; 29(5):819-830. PubMed ID: 30872350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma.
    Saigo K; Yoshida K; Ikeda R; Sakamoto Y; Murakami Y; Urashima T; Asano T; Kenmochi T; Inoue I
    Hum Mutat; 2008 May; 29(5):703-8. PubMed ID: 18320596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
    Ishii T; Tamura A; Shibata T; Kuroda K; Kanda T; Sugiyama M; Mizokami M; Moriyama M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
    Zhao LH; Liu X; Yan HX; Li WY; Zeng X; Yang Y; Zhao J; Liu SP; Zhuang XH; Lin C; Qin CJ; Zhao Y; Pan ZY; Huang G; Liu H; Zhang J; Wang RY; Yang Y; Wen W; Lv GS; Zhang HL; Wu H; Huang S; Wang MD; Tang L; Cao HZ; Wang L; Lee TL; Jiang H; Tan YX; Yuan SX; Hou GJ; Tao QF; Xu QG; Zhang XQ; Wu MC; Xu X; Wang J; Yang HM; Zhou WP; Wang HY
    Nat Commun; 2016 Oct; 7():12992. PubMed ID: 27703150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
    Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
    Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue.
    Yang X; Wu L; Lin J; Wang A; Wan X; Wu Y; Robson SC; Sang X; Zhao H
    Int J Cancer; 2017 Mar; 140(6):1324-1330. PubMed ID: 27943263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.
    Chen W; Zhang K; Dong P; Fanning G; Tao C; Zhang H; Guo S; Wang Z; Hong Y; Yang X; Lai S; Ding H; Zhao H; Zeng C; Protzer U; Zhang D
    Hepatol Int; 2020 May; 14(3):326-337. PubMed ID: 32100258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.
    Ding D; Lou X; Hua D; Yu W; Li L; Wang J; Gao F; Zhao N; Ren G; Li L; Lin B
    PLoS Genet; 2012; 8(12):e1003065. PubMed ID: 23236287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
    Sung WK; Zheng H; Li S; Chen R; Liu X; Li Y; Lee NP; Lee WH; Ariyaratne PN; Tennakoon C; Mulawadi FH; Wong KF; Liu AM; Poon RT; Fan ST; Chan KL; Gong Z; Hu Y; Lin Z; Wang G; Zhang Q; Barber TD; Chou WC; Aggarwal A; Hao K; Zhou W; Zhang C; Hardwick J; Buser C; Xu J; Kan Z; Dai H; Mao M; Reinhard C; Wang J; Luk JM
    Nat Genet; 2012 May; 44(7):765-9. PubMed ID: 22634754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).
    Wang W; Chen Y; Wu L; Zhang Y; Yoo S; Chen Q; Liu S; Hou Y; Chen XP; Chen Q; Zhu J
    BMC Med Genomics; 2022 Jun; 15(1):134. PubMed ID: 35710421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
    Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
    Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIVID: an efficient method to detect HBV integration using low coverage sequencing.
    Li W; Zeng X; Lee NP; Liu X; Chen S; Guo B; Yi S; Zhuang X; Chen F; Wang G; Poon RT; Fan ST; Mao M; Li Y; Li S; Wang J; Jianwang ; Xu X; Jiang H; Zhang X
    Genomics; 2013 Oct; 102(4):338-44. PubMed ID: 23867110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.